Aspire Biopharma
(NASDAQ) ASBP
Aspire Biopharma Financials at a Glance
Market Cap
$1.35M
Revenue (TTM)
$6.20K
Net Income (TTM)
$24.48M
EPS (TTM)
$-21.26
P/E Ratio
-0.01
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Price
$0.28
Volume
25,520
Open
$0.32
Price
$0.28
Volume
25,520
Open
$0.32
Previous Close
$0.27
Daily Range
$0.23 - $0.33
52-Week Range
$0.23 - $35.01
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Price
$0.28
Volume
25,520
Open
$0.32
Previous Close
$0.27
Daily Range
$0.23 - $0.33
52-Week Range
$0.23 - $35.01
ASBP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aspire Biopharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
2
CEO
Kraig T. Higginson
Website
www.aspirebiolabs.comHeadquarters
Estero, FL 33928, US
ASBP Financials
Key Financial Metrics (TTM)
Gross Margin
-2%
Operating Margin
-842%
Net Income Margin
-3947%
Return on Equity
-490%
Return on Capital
83%
Return on Assets
-19%
Earnings Yield
-100.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.35M
Shares Outstanding
5.02M
Volume
25.52K
Short Interest
0.00%
Avg. Volume
1.34M
Financials (TTM)
Gross Profit
$116.00
Operating Income
$19.35M
EBITDA
$19.35M
Operating Cash Flow
$4.92M
Capital Expenditure
$0.00
Free Cash Flow
$4.92M
Cash & ST Invst.
$1.00M
Total Debt
$1.38M
Aspire Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.26K
N/A
Gross Profit
$1.00K
N/A
Gross Margin
-23.47%
N/A
Market Cap
$1.35M
N/A
Market Cap/Employee
$677.50K
N/A
Employees
2
N/A
Net Income
$4.71M
+47.3%
EBITDA
$3.90M
+54.9%
Quarterly Fundamentals
Net Cash
$380.87K
+69.8%
Accounts Receivable
$0.00
-100.0%
Inventory
$253.16K
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$1.38M
+9.3%
Return on Assets
-18.66%
N/A
Return on Invested Capital
83.11%
N/A
Free Cash Flow
$927.84K
-136.2%
Operating Cash Flow
$927.84K
-136.2%